Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2016

Segment Reporting Information By Segment

A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying unaudited condensed consolidated statements of operations is as follows:



	Three Months Ended June 30,						Six Months Ended June 30,
(in millions)	2016			2015			2016			2015

Net sales
Interventional Cardiology	$	635		$	567		$	1,248		$	1,108
Peripheral Interventions	278			245			542			477
Cardiovascular	913			812			1,790			1,585

Cardiac Rhythm Management	512			490			983			973
Electrophysiology	64			60			128			121
Rhythm Management	576			550			1,111			1,094

Endoscopy	390			352			755			680
Urology and Pelvic Health	270			142			513			272
Neuromodulation	139			125			264			241
MedSurg	799			619			1,532			1,193
Net sales allocated to reportable segments	2,288			1,981			4,433			3,872
Impact of foreign currency fluctuations	(162		)	(138		)	(343		)	(261		)
	$	2,126		$	1,843		$	4,090		$	3,611

Income (loss) before income taxes
Cardiovascular	$	294		$	247		$	593		$	483
Rhythm Management	97			78			187			155
MedSurg	262			188			502			355
Operating income allocated to reportable segments	653			513			1,282			993
Corporate expenses and currency exchange	(155		)	(105		)	(290		)	(188		)
Intangible asset impairment charges; acquisition- and divestiture-, restructuring- and restructuring-related net charges; litigation-related net charges and credits; and pension termination charges	(697		)	(73		)	(762		)	(333		)
Amortization expense	(135		)	(116		)	(271		)	(229		)
Operating income (loss)	(334		)	219			(41		)	243
Other expense, net	(63		)	(114		)	(128		)	(189		)
Income (loss) before income taxes	$	(397	)	$	105		$	(169	)	$	54